Oct
2026
Fiera Milano, Italy
Visit us
stand 11A41, Packaging & Drug Delivery
Phillips Medisize
Exhibitor at CPHI Milan 2026
About Us
Categories
-
Country/Region:United States
-
On CPHI since:2022
-
Employees:5000+
Company types
Primary activities
Event information
CPHI Milan 2026
-
6 Oct 2026 - 8 Oct 2026
-
Fiera Milano, Italy
-
Visit us at stand 11A41, Packaging & Drug Delivery
Products Featured at CPHI Milan 2026
-
Product Aria Smart Autoinjector
A Reusable Autoinjector with a Disposable Cassette
Phillips Medisize is developing an innovative smart autoinjector that is designed to combine the ease of use of a disposable autoinjector with the flexibility of a reusable electronic device.
Designed to be: • Reusable for... -
Product Envoi Pen Injector
A Familiar Pen Injector at an Affordable Price
The Envoi Pen Injector is a compact and user-friendly pen device designed for the subcutaneous delivery of medication. It is intended to be used for self-administration of injectable medications, including insulin and glucagon-like peptide-1 (GLP-1).... -
Product FOX™ Vibrating Mesh Nebulizer
The FOX device is a small, handheld, breath-activated, battery-powered inhalation system that delivers nebulized liquid drugs with high performance using a vibrating mesh technology. The device is CE marked and has a 510(k) premarket notification for marketing in the US.
The FOX device is suitab... -
Product GyroHaler™
• 60-dose DPI device with intuitive user interface • Approved and marketed in the UK, EU and Rest of World -
Product Lever-operated Multidose Inhaler (LOMI)
• 60-dose DPI device with four user steps • Approved and marketed in the US
Phillips Medisize Resources (1)
-
Brochure Adding Market-Leading Inhalation Capabilities to Our Suite of Drug Delivery Device Design and Production Capabilities
Combining the strengths of Phillips Medisize and Vectura enhances our ability to deliver a broader portfolio of innovative inhalation solutions to our pharmaceutical partners and to fulfill our shared vision of helping patients live healthier lives.
Together, we can offer a wider range of formulation, device design and combination product development, as well as manufacturing services to support the growing global need for inhaled therapies to treat chronic respiratory diseases like asthma and COPD, as well as for non-respiratory conditions.


